Large proportion still unaware they have HIV, say UNAIDS report
US government seeks more info on Sovaldi pricing
NICE's value assessments may restrict patient access
UK NICE aims to expand statin use to reduce CVD deaths
NICE standard for hepatitis B
Air humidification therapy "moderately cost-effective" in NZ
BAL-directed therapy not worth it in kids with CF
Barrett's oesophagus worth watching
CancerTYPE ID test cost effective in cancer diagnosis
Bronchial thermoplasty worth it for asthma in Italy
Cost an important factor for uptake of new anticoagulants
Compensation for circumcision makes the cut in Kenya
Costs of inadequate allergy care in EU: GA2LEN review
Dependent coverage provision reaps benefits in US
Diagnostic needle arthroscopy could be cost saving in US
Costs, resource use of prostate cancer higher with metastases?
HLA-B5801 genotyping of gout reduces costs
HPV vax catch-up programme could pay off in Norway
HPV vax uptake remains low in US, despite being "safe and effective"
Monitoring inactive hep B carriers worth it in China?
Increasing uptake of peritoneal dialysis in ESRD cost saving in UK
Meningococcal survivers exact sizeable burden in Spain
The skinny on phentermine/topiramate for obesity
Opioid use, costs and harm increasing in Australia
Switch to generic lamotrigine a good move in NZ?
Medical home programme holds firm on cost, quality in US
UK NHS plans to recover costs of migrant and visitor healthcare
Lubiprostone backed up by NICE for constipation
Two new cancer treatments given green light by UK NICE
Prasugrel recommended for ACS by UK NICE
UK NICE turns 15
UK NICE issues draft guidance on new breast cancer radiotherapy